Table 3.
HR (95% CI) a | P value | |
---|---|---|
Age + AF adjusted | 2.16 (1.26–3.71) | 0.005 |
Age + haemoglobin adjusted | 2.05 (1.21–3.46) | 0.007 |
Age + Ln eGFR adjusted | 1.82 (1.07–3.07) | 0.03 |
Age + Ln LA volume index adjusted | 2.14 (1.30–3.51) | 0.003 |
Age + Ln NT‐proBNP adjusted | 1.89 (1.11–3.25) | 0.02 |
Haemoglobin + Ln eGFR adjusted | 1.83 (1.05–3.16) | 0.03 |
Haemoglobin + Ln NT‐proBNP adjusted | 1.91 (1.05–3.53) | 0.04 |
Ln eGFR + Ln NT‐proBNP adjusted | 1.80 (1.04–3.16) | 0.04 |
AF, atrial fibrillation; eGFR, estimated glomerular filtration rate; LA, left atrial; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.
Hazard ratios (HRs) and 95% confidential intervals (CIs) for Ln FABP4 per 1 unit increase.